Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1996-02-21
1998-07-07
Draper, Garnette D.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4352523, 4353201, 435 71, 536 235, C12N 1509
Patent
active
057767319
ABSTRACT:
2F1 polypeptides members of the IL-1 receptor family are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
REFERENCES:
patent: 5488032 (1996-01-01), Dower et al
Gayle et al JBC 271 (10) p 5784-89.
Mitcham et al FBC 271(10) 3/95 pp. 5777-83.
Lui et al J. Neuroimmunology 66, 5/96 pp. 41-48.
Parnet et al JBC 271 (8) 2/96, pp 3967-70.
Motohashi et al, EST/STS sequence databank, #D76008, sub 8/95.
Frommel et al, J. Mol Eval 21, 1985, pg 233-57.
Ngo et al, "The Protein Folding Problem", ed Merz et al, 1994, pp. 491-94.
Bowie et al, Serenel vol 247, 1990, pp 1306-10.
Norbert W. Tietz, Ph.D., "7-Lipids, Lipoproteins, and Apolipoproteins", Textbook of Clinical Chemistry, p. 842.
Isselbacher et al., "Eicosanoids and Human Diease", Harrison 's Principles of Internal Medicine, (13):433-435.
Baum et al., "Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34", The EMBO Journal, 13(17) :3992-4001, 1994.
Bergers et al., "Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor", EMBO Journal , 13(5):1176-1188, 1994.
Hashimoto et al., "The Toll Gene of Drosophila, Required for Dorsal-Ventral Embryonic Polarity, Appears to Encode a Transmembrane Protein", Cell, 52:269-279, Jan. 29, 1988.
Arend et al., "Binding of IL-1.alpha., IL-1.beta., and IL-1 Receptor Antagonist by Soluble IL-1 Receptors and Levels of Soluble IL-1 Receptors in Synovial Fluids", The Journal of Immunology, 153 (10): 4767-4774, Nov. 15, 1994.
Jean Marx, "How the Glucocorticoids Suppress Immunity", Science, 270:232-233, Oct. 13, 1995.
Auphan et al., "Immunosuppression by Glucocorticoids: Inhibition of NF-kB Activity Through Induction of IkB Synthesis", Science, 270:286-290, Oct. 13, 1995.
Howard et al., "Soluble tumor necrosis factor receptor: Inhibition of human immunodeficiency virus activation", Proc. Natl. Acad. Sci. USA, 90:p. 2335, Mar. 1993.
Yamamoto et al., "Transcriptional Roles of Nuclear Factor kB and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor .alpha.-Dependent Induction of Cyclooxyhenase-2 in MC3T3-E1 Cells", The Journal of Biological Chemistry , 270(52):31315-31320, 1995.
Weih et al., "Multiorgan Inflammation and Hematopoietic Abnormalities in Mice with a Targeted Disruption of ReIB, a Memeber of the NF-kB/Rel Family", Cell , 80:331-340, Jan. 27, 1995.
Sha et al., "Targeted Disruption of the p50 Subunit of NF-kB Leads to Multifocal Defects in Immune Responses", Cell , 80:321-330, Jan. 27, 1995.
Thanos et al., "NF-kB: A Lesson in Family Values", Cell , 80:529-532, Feb. 24, 1995.
Carter et al., "Purification, cloning, expression, and biological characterization of an interleukin-1 receptor antagonist protein", Nature , 344:633-637, Apr. 12, 1990.
Nomura et al., "Prediction of the Coding Sequences of Unidentified Human Genes. I. The Coding Sequences of 40 New Genes (KIAA0001-KIAA0040) Deduced by Analysis of Randomly Sampled cDNA Clones from Human Immature Myeloid Cell Line KG-1", DNA Research , 1:27-35,1994.l
Lord et al., "Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6", Oncogene , 5(7):1095-1097, Jul. 1990.
Greenfeder et al., "Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex", The Journal of Biological Chemistry , 270(23):13757-13765, 1995.
Sims et al., "Genomic Organization of the Type I and Type II IL-1 Receptors", Cytokine, 7(6):483-490, Aug. 1995.
Price et al., "Pathophysiology Clinical Concepts of Disease Processes", pp. 36-38, 1986.
Crowell et al., "Functional Bowel Disorders and Dysmenorrhea: Don 't Cramp My Style", Gastroenterology, 109(3):1017-1019, Sep. 1995.
Charles A. Dinarello, "Interleukin-1 and Its Biologically Related Cytokines", Advances in Immunology, 44:153-205, 1989.
William P. Arend, "Interleukin-1 Receptor Antagonist", Advances in Immunology, 54:167-227, Jan. 19, 1993.
Parnet et al., "A Novel Receptor Similar to the Type I Interleukin 1 Receptor and T1/ST2", Poster presented at Lake George, NY, October 1995.
Rosenberg et al., "Immunopathogenesis of HIV Infection", FASEB Journal. 5:p.2384, Jul. 1991.
Anthony S. Fauci, "Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for Therapy", Science, 262:1011-1014, Nov. 12, 1993.
Parnet Patricia
Sims John E.
Anderson Kathryn A.
Draper Garnette D.
Henry Janis C.
Immunex Corporation
LandOfFree
DNA encoding type-I interleukin-I receptor-like protein designat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding type-I interleukin-I receptor-like protein designat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding type-I interleukin-I receptor-like protein designat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1204384